News Sentiment

REPL sentiment intelligence

Replimune Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.23 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-6.9% over one week, +0.4% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Replimune stock gains after updated RP1 data and cash runway outlook

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -6.9% Price reacting lower
Trend fit Trend active 0.4% over four weeks
Fair value 5.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 40
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 9
Stock Titan 7
Ad-hoc-news.de 4
MT Newswires 4
Investing.com 3
simplywall.st 3
Stocktwits 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 19
Analyst action 7
Regulatory and legal 5
Guidance 2
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
TradingView Direct company coverage

Enterprise value to EBITDA forward of Replimune Group, Inc. – NASDAQ:REPL

The article focuses on the enterprise value to EBITDA forward for Replimune Group, Inc. (NASDAQ: REPL). It appears to be a financial data snippet or a specific page from a financial tracking platform like TradingView, providing a value for this financial metric. The content itsel

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 13:09
Source
TradingView
Stock Titan Direct company coverage

FDA accepts Replimune’s melanoma drug review, decision due Aug. 2

Replimune announced that the FDA has accepted for review its resubmitted Biologics License Application (BLA) for RP1 combined with nivolumab for advanced melanoma. The FDA classified it as a complete, class 1 response, setting an action date of August 2, 2026, and plans an adviso

Tone
Positive 87/100
Event
Market update
Published
26 Jun 2026 12:09
Source
Stock Titan
TradingView Direct company coverage

Replimune: FDA Accepts RP1 BLA Resubmission with Aug. 2, 2026 Goal Date

The FDA has accepted Replimune's Biologics License Application (BLA) resubmission for RP1 (vusolimogene oderparepvec) with nivolumab for advanced melanoma. The resubmission is categorized as a complete, class 1 response, and the FDA has set a target action date of August 2, 2026,

Tone
Positive 72/100
Event
Analyst action
Published
26 Jun 2026 12:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Replimune Group, Inc. – SWB:7R8

This page from TradingView provides financial information for Replimune Group, Inc. (SWB:7R8), specifically focusing on its price-to-earnings forward metric. The content appears to be a stub or a placeholder, as the actual financial data for the chosen period is missing or not di

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 17:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Replimune Group, Inc. – SWB:7R8

This article provides financial information for Replimune Group, Inc. (SWB:7R8) on TradingView, specifically focusing on its price-to-sales forward metric. It highlights the company's stock exchange listing and various financial data points available to users. The content primari

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 00:10
Source
TradingView